Clinical Trials Logo

Chronic Urticaria, Idiopathic clinical trials

View clinical trials related to Chronic Urticaria, Idiopathic.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05916937 Recruiting - Clinical trials for Chronic Spontaneous Urticaria

Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria

EXOTIC
Start date: January 12, 2024
Phase: Phase 4
Study type: Interventional

This study is a multicentre, randomized, open-label, non-inferiority clinical trial. The purpose and aim of this study is to investigate if patients with well controlled (UCT score score ≥ 12) chronic spontaneous urticaria (CSU) on omalizumab 300 mg every four weeks can extend treatment intervals and maintain disease control.

NCT ID: NCT04774315 Recruiting - Clinical trials for Chronic Urticaria, Idiopathic

Molecular Endotypes of Chronic Idiopathic Urticaria

Start date: January 1, 2022
Phase: Phase 4
Study type: Interventional

This study plans to learn more about why some people with Chronic Idiopathic Urticaria (CIU) respond to treatment with omalizumab (Xolair). It will test people before they receive treatment with omalizumab as part of standard of care, to see if there are differences in their blood and skin that can predict who responds to treatment.